Here are five key developments in stem cell treatments for spine and orthopedics. By Alan Condon - 8/23/19

Fairlawn, Ohio-based Crystal Clinic Orthopaedic Center is using biologic therapies to treat anterior cruciate ligament and joint-related injuries. By Eric Oliver - 8/20/19

Richard Kim, MD, is using stem cells to help relieve patient pain at his private practice in Saratoga Springs, N.Y. By Eric Oliver - 8/19/19

Ortho Regenerative Technologies reported a successful pre-investigational drug meeting with the FDA in February and is now preparing for its rotator cuff phase I/II clinical trial. By Alan Condon - 8/14/19

In July, orthobiologics company Biogennix hit its best ever month for sales since its formation in 2009. By Alan Condon - 8/14/19

Biofirma, a subsidiary of IMAC Holdings, received "registered" status by the FDA. By Alan Condon - 8/14/19

A study published in Stem Cells Translational Medicine found that an injection of human amniotic fluid stem cells can be used to protect the spinal cord of a fetus from myelomeningocele. By Alan Condon - 8/14/19

John Tierney, DO, used Anika Therapeutics' injectable hyaluronic acid-based bone repair product in a patient. By Eric Oliver - 8/13/19

Bioventus plans to expand Durolane, its hyaluronic acid joint-fluid osteoarthritis injection, into Australia and New Zealand. By Alan Condon - 8/13/19

Daniel Penello, MD, of Alexander Orthopaedic Associates in St. Petersburg, Fla., is a fellowship-trained orthopedic surgeon who specializes in hand and upper extremity surgery. By Alan Condon - 8/12/19

A group of orthobiologics experts established a Delphi panel process to set treatment standards for an outpatient stem cell procedure known as bone marrow concentrate. By Alan Condon - 8/9/19

PTC Therapeutics is leasing a 185,000-square-foot biologics-focused research space from Bristol-Myers Squibb, BioPharmaReport.com reports. By Eric Oliver - 8/9/19

The California Institute for Regenerative Medicine has been instrumental in stem cell research since it was first established in 2004, but it faces closure in 2022 if a ballot initiative to get it more funding is unsuccessful.  By Eric Oliver - 8/8/19

Discgenics treated the first patients in its clinical trial of intervertebral disc tissue for mild to moderate degenerative disc disease in Japan, reports Biospectrum Asia. By Alan Condon - 8/8/19

Andreas Gomoll, MD, implanted Cartiheal's Agili-C in two patients in an investigational device exemption study at Hospital for Special Surgery in New York City. By Alan Condon - 8/8/19

NanoFuse Biologics is launching its biologic in Panama City, Panama, through a partnership with medical distributor PTY Medical Group. By Alan Condon - 8/7/19

Camber Spine is widening its portfolio by tapping into the biologics market. By Alan Condon - 8/7/19

Biologics development company AgeX Therapeutics added Michael May, PhD, to its board of directors, returning it to full strength. By Eric Oliver - 8/6/19

Chad Kurtenbach, MD, of Sioux Falls, S.D.-based Sanford Health is conducting a study of a stem cell treatment for patients with osteoarthritis in the knee. By Alan Condon - 7/31/19

Biologics has the potential to be the next transformative tool in the orthopedic surgeon's playbook, but the field still has a ways to go before it becomes a mainstream medicinal offering. By Eric Oliver - 7/31/19